About
FDA Releases Discussion Paper on AI in the Drug and Biological Product Development Process
FDA Releases Draft Guidance on Electronic Systems, Records, and Signatures in Clinical Investigations

FDA Seeks Comments on Agency Actions to Advance Use of AI and Digital Health Technologies in Drug Development
5 Digital Health Issues to Watch at FDA in 2022
FDA Issues Final Guidance on Multiple Function Digital Health Software and Other Devices
Client Alert: FDA Issues Temporary Guidance on New CARES Act Provision Requiring Certain Device Notifications to CDRH
FDA Issues COVID-19 Policy for Certain Digital Health Solutions
